Pfizer Branches Out with Stem Cell Therapy Investment

With each passing day, old-line drug company Pfizer ( PFE ), the name behind cholesterol-lowering drug Lipitor and erectile-dysfunction treatment Viagra, is acting increasingly like a young biotech firm. The latest development? New York-based Pfizer is licensing a new stem cell therapy for inflammatory bowel disease biotech firm Athersys ( ATHX ), the Cleveland, Ohio-based company said. Continue reading Pfizer Branches Out with Stem Cell Therapy Investment Pfizer Branches Out with Stem Cell Therapy Investment originally appeared on DailyFinance on Mon, 21 Dec 2009 18:45:00. Filed Under: Company News , Healthcare , Pfizer Permalink | Tweet this! | Comments

Original post: 
Pfizer Branches Out with Stem Cell Therapy Investment

Tagged with: athersys • cell-therapy • chronsdisease • entry • geron • multistem • pfizer • president-obama • stem cells • stemcells • therapy • therapy-investment • young-biotech

Filed under: Business News

Like this post? Subscribe to my RSS feed and get loads more!